RPCONE
TAK icon

Retirement Planning Company of New England’s Takeda Pharmaceutical TAK Stock Holding History

Retirement Planning Company of New England’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,421
Closed -$73K – 798
2021
Q4 		$73K Buy
+5,421
New +$76K 0.04% 351

Other funds holding TAK

PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Planning Company of New England's TAK Position: Q1 2022 in Review

Retirement Planning Company of New England sold out of Takeda Pharmaceutical (TAK) in Q1 2022, closing a stake of 5,421 shares — an estimated $73K sold.

Retirement Planning Company of New England first reported a position in TAK in Q4 2021 and held it in 1 quarter. The position peaked at $73K in Q4 2021. 288 funds tracked by Wall St. Rank hold TAK as of Q1 2022.

  • Retirement Planning Company of New England reported no remaining Takeda Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • Retirement Planning Company of New England sold 5,421 Takeda Pharmaceutical shares in Q1 2022, an estimated $73K.
  • Retirement Planning Company of New England first reported a position in Takeda Pharmaceutical in Q4 2021 and held it in 1 quarter.
  • Retirement Planning Company of New England's Takeda Pharmaceutical position peaked at $73K in Q4 2021.
  • 288 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2022.

Based on Retirement Planning Company of New England's 13F filing for Q1 2022, filed 6 May 2022.